CIndU Care: Antihistamine Up-Titration Anchors a Still-Gappy Algorithm
CIndU management still hinges on up-titrating H1-antihistamines up to fourfold, but experts flag thin subtype-specific evidence and a sparse pipeline beyond omalizumab.
Topic
Antihistamines
Topic
Antihistamines
FDA Expands Urticaria Drug Indication to Symptomatic Dermographism
The FDA has expanded a urticaria drug's indication to treat symptomatic dermographism, moving a common inducible urticaria into o…